Key Details
Price
$4.05Annual ROE
-46.62%Beta
0.37Events Calendar
Next earnings date:
May 7, 2025Recent quarterly earnings:
Nov 14, 2024Recent annual earnings:
Mar 22, 2023Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
May 16, 2023Analyst ratings
Recent major analysts updates
Oct 20, 21 Truist Securities
BuySep 24, 21 Cantor Fitzgerald
OverweightMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price
Market cap
Technical
Dividend
Cyclerion Therapeutics doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Equity
Liabilities
Debt
Expenses
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
Cyclerion's sGC Stimulator Portfolio Generates Revenues to Enable Company Growth
CYCN
globenewswire.comDecember 17, 2024
CAMBRIDGE, Mass., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (Nasdaq: CYCN), today announced an update on its progress in catalyzing the Company's next stage of growth.
Regina Graul, Ph.D., Promoted to Chief Executive Officer
CYCN
globenewswire.comAugust 7, 2024
CAMBRIDGE, Mass., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (Nasdaq: CYCN), today announced that Regina Graul, Ph.D.
FAQ
- What is the ticker symbol for Cyclerion Therapeutics?
- Does Cyclerion Therapeutics pay dividends?
- What sector is Cyclerion Therapeutics in?
- What industry is Cyclerion Therapeutics in?
- What country is Cyclerion Therapeutics based in?
- When did Cyclerion Therapeutics go public?
- Is Cyclerion Therapeutics in the S&P 500?
- Is Cyclerion Therapeutics in the NASDAQ 100?
- Is Cyclerion Therapeutics in the Dow Jones?
- When was Cyclerion Therapeutics's last earnings report?
- When does Cyclerion Therapeutics report earnings?
- Should I buy Cyclerion Therapeutics stock now?
What is the ticker symbol for Cyclerion Therapeutics?
The ticker symbol for Cyclerion Therapeutics is NASDAQ:CYCN
Does Cyclerion Therapeutics pay dividends?
No, Cyclerion Therapeutics does not pay dividends
What sector is Cyclerion Therapeutics in?
Cyclerion Therapeutics is in the Healthcare sector
What industry is Cyclerion Therapeutics in?
Cyclerion Therapeutics is in the Biotechnology industry
What country is Cyclerion Therapeutics based in?
Cyclerion Therapeutics is headquartered in United States
When did Cyclerion Therapeutics go public?
Cyclerion Therapeutics's initial public offering (IPO) was on March 18, 2019
Is Cyclerion Therapeutics in the S&P 500?
No, Cyclerion Therapeutics is not included in the S&P 500 index
Is Cyclerion Therapeutics in the NASDAQ 100?
No, Cyclerion Therapeutics is not included in the NASDAQ 100 index
Is Cyclerion Therapeutics in the Dow Jones?
No, Cyclerion Therapeutics is not included in the Dow Jones index
When was Cyclerion Therapeutics's last earnings report?
Cyclerion Therapeutics's most recent earnings report was on Nov 14, 2024
When does Cyclerion Therapeutics report earnings?
The next expected earnings date for Cyclerion Therapeutics is May 7, 2025
Should I buy Cyclerion Therapeutics stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions